These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of HHV-8 in Kaposi's sarcoma. Neipel F; Fleckenstein B Semin Cancer Biol; 1999 Jun; 9(3):151-64. PubMed ID: 10343067 [TBL] [Abstract][Full Text] [Related]
3. AIDS-related Kaposi's sarcoma: principal pathogenic mechanisms. Silvestris N J Exp Clin Cancer Res; 1999 Sep; 18(3):311-5. PubMed ID: 10606175 [TBL] [Abstract][Full Text] [Related]
4. Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Ensoli B; Stürzl M; Monini P Semin Cancer Biol; 2000 Oct; 10(5):367-81. PubMed ID: 11100885 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and manifestations of human herpesvirus-8-associated disorders. Aoki Y; Tosato G Semin Hematol; 2003 Apr; 40(2):143-53. PubMed ID: 12704591 [TBL] [Abstract][Full Text] [Related]
6. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Connick E; Kane MA; White IE; Ryder J; Campbell TB Clin Infect Dis; 2004 Dec; 39(12):1852-5. PubMed ID: 15578411 [TBL] [Abstract][Full Text] [Related]
7. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma. Gramolelli S; Schulz TF J Pathol; 2015 Jan; 235(2):368-80. PubMed ID: 25212381 [TBL] [Abstract][Full Text] [Related]
8. Spindle cells and their role in Kaposi's sarcoma. Gessain A; Duprez R Int J Biochem Cell Biol; 2005 Dec; 37(12):2457-65. PubMed ID: 16188485 [TBL] [Abstract][Full Text] [Related]
9. Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma. Duprez R; Lacoste V; Brière J; Couppié P; Frances C; Sainte-Marie D; Kassa-Kelembho E; Lando MJ; Essame Oyono JL; Nkegoum B; Hbid O; Mahé A; Lebbé C; Tortevoye P; Huerre M; Gessain A J Natl Cancer Inst; 2007 Jul; 99(14):1086-94. PubMed ID: 17623796 [TBL] [Abstract][Full Text] [Related]
10. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis. Fiorelli V; Barillari G; Toschi E; Sgadari C; Monini P; Stürzl M; Ensoli B J Immunol; 1999 Jan; 162(2):1165-70. PubMed ID: 9916748 [TBL] [Abstract][Full Text] [Related]
15. Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma. Simonart T Cancer Lett; 2006 Nov; 244(1):1-7. PubMed ID: 16542773 [TBL] [Abstract][Full Text] [Related]
16. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma. Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468 [TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma: a model of both malignancy and chronic inflammation. Douglas JL; Gustin JK; Dezube B; Pantanowitz JL; Moses AV Panminerva Med; 2007 Sep; 49(3):119-38. PubMed ID: 17912148 [TBL] [Abstract][Full Text] [Related]
19. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. Guo HG; Pati S; Sadowska M; Charurat M; Reitz M J Virol; 2004 Sep; 78(17):9336-42. PubMed ID: 15308728 [TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 8: current issues. Cannon MJ; Laney AS; Pellett PE Clin Infect Dis; 2003 Jul; 37(1):82-7. PubMed ID: 12830412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]